| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 05/16/2002 | WO2001072292A3 Vitamin d compounds used to stabilize kidney transplants |
| 05/16/2002 | US20020058630 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 05/15/2002 | EP1204657A1 Piperidine and pyrrolidine derivatives displaying neuronal activity |
| 05/15/2002 | EP1204433A1 Joint lubricant |
| 05/15/2002 | CN1348763A Medicine composite for preventing or treaitng diseases relating to IL-12 over growth |
| 05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
| 05/10/2002 | WO2002036751A2 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 05/10/2002 | WO2002036162A2 Compositions for treatment of ocular neovascularization and neural injury |
| 05/10/2002 | WO2002016381A3 Composition and method for inhibiting platelet aggregation |
| 05/10/2002 | WO2001064650A3 Synthesis of epothilones, intermediates thereto and analogues thereof |
| 05/10/2002 | WO2001064214A3 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| 05/10/2002 | WO2001000246A3 Hydrogels derived from chitosan and poly(ethylene glycol) |
| 05/10/2002 | CA2426987A1 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 05/08/2002 | EP1203008A1 Nucleic acid ligands to cd40ligand |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1202994A1 New compounds |
| 05/08/2002 | EP1202754A1 Use of fibrinogen multimers in fibrin sealants |
| 05/08/2002 | EP1024823B1 Prevention and treatment of adhesion formation |
| 05/08/2002 | CN1348381A Treatment with small peptides to effect antifibrotic activity |
| 05/07/2002 | US6383511 Local prevention or amelioration of pain from surgically closed wounds |
| 05/07/2002 | US6383484 Antibodies to truncated VEGF-D and thereof |
| 05/02/2002 | WO2002034258A1 Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery |
| 05/02/2002 | WO2002034250A1 Fat emulsions |
| 05/02/2002 | WO2002034202A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | WO2001098473A3 Method for isolating and purifying a protein and resulting protein |
| 05/02/2002 | WO2001077137A9 Albumin fusion proteins |
| 05/02/2002 | US20020052337 Composition and method for inhibiting platelet aggregation |
| 05/02/2002 | EP1200582A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/02/2002 | DE10049483A1 Substituierte 1-Aminobutan-3-ol-Derivate Substituted 1-aminobutan-3-ol derivatives |
| 05/02/2002 | CA2427005A1 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | CA2419373A1 Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery |
| 04/25/2002 | WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 04/25/2002 | WO2002032461A2 Protein c or activated protein c-like molecules |
| 04/25/2002 | WO2002032447A2 Cell damage inhibitor |
| 04/25/2002 | WO2002032422A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | WO2002022112A9 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 04/25/2002 | WO2001057240A3 Interaction of nmda receptor with protein tyrosine phosphatase |
| 04/25/2002 | WO2001046327A3 1,1-disubstituted ethylene adhesive compositions containing polydimethylsiloxane |
| 04/25/2002 | CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | CA2426381A1 Cell damage inhibitor |
| 04/25/2002 | CA2425221A1 Protein c or activated protein c-like molecules |
| 04/24/2002 | CN1346282A Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as combination therapy method in treating neoplasia |
| 04/18/2002 | WO2002030990A1 Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof |
| 04/18/2002 | WO2002030485A1 Embolic materials |
| 04/18/2002 | WO2002030446A2 Reduction or prevention of post-surgical adhesion formation with fibrinogen |
| 04/18/2002 | WO2002030445A2 Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation |
| 04/18/2002 | WO2002030444A2 Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 04/18/2002 | CA2423595A1 Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 04/17/2002 | EP1196186A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 04/17/2002 | CN1345331A Method and composition for angiogenesis inhibition |
| 04/16/2002 | US6372723 Administering selective adenosine a2a receptor agonist and/or antagonist; occlusion removal; surgery; reroute blood flowthrough bypass graft |
| 04/11/2002 | WO2002028817A1 Substituted 1-aminobutan-3-ol derivatives |
| 04/11/2002 | WO2001090070A3 Caspase inhibitors and uses thereof |
| 04/11/2002 | WO2001085671A3 Anthranyl amides and their use as medicaments |
| 04/11/2002 | US20020042043 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 04/11/2002 | CA2423860A1 Substituted 1-aminobutan-3-ol derivatives |
| 04/10/2002 | EP1194441A2 Thiophene a2a receptor agonists |
| 04/09/2002 | CA2298572C Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/04/2002 | WO2002026935A2 TGF-β INHIBITORS AND METHODS |
| 04/04/2002 | WO2002026694A1 O-substituted 6-methyl-tramadol derivatives |
| 04/04/2002 | WO2001094347A8 Tetracyclic diketopiperazine compounds as pdev inhibitors |
| 04/04/2002 | CA2423903A1 O-substituted 6-methyltramadol derivatives |
| 04/04/2002 | CA2421851A1 Tgf-.beta. inhibitors and methods |
| 04/03/2002 | CN1343213A 2,3-0-isopropylidene derivatives of monosaccharides as cell adhesive inhibitors |
| 03/28/2002 | WO2002024218A1 Angiogenic agents and their uses |
| 03/28/2002 | WO2001083522A3 Growth factor modified protein matrices for tissue engineering |
| 03/28/2002 | WO2001066107A3 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 03/28/2002 | WO2001032216A3 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 03/28/2002 | US20020037919 Compositions and methods of paclitaxel for preventing psoriasis |
| 03/28/2002 | US20020037900 Hydroxamic acid derivatives |
| 03/28/2002 | US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections |
| 03/28/2002 | US20020035996 Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery |
| 03/27/2002 | EP1189618A1 Thrombin inhibitors |
| 03/27/2002 | CN1342171A Process for production of multiple cross-linked hyaluronic acid derivatives |
| 03/21/2002 | WO2002022776A2 Human coagulation factor vii variants |
| 03/21/2002 | WO2002022611A2 Caspase inhibitors and uses thereof |
| 03/21/2002 | WO2002022166A2 Tweak receptor agonists as anti-angiogenic agents |
| 03/21/2002 | WO2002022112A2 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 03/21/2002 | WO2001085179A3 Biological joint lubricant composition and method of applying |
| 03/21/2002 | CA2422095A1 Tweak receptor agonists as anti-angiogenic agents |
| 03/21/2002 | CA2418720A1 Caspase inhibitors and uses thereof |
| 03/20/2002 | EP1188438A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production |
| 03/19/2002 | US6359003 Fumaric acid alkyl esters for suppressing host versus graft reaction |
| 03/19/2002 | US6358741 Polynucleotide coding propagation regulator; for treating cell proliferative defects |
| 03/15/2002 | CA2357155A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 03/14/2002 | WO2002020619A2 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 03/14/2002 | WO2002020005A1 Use of arginine in endoscopy and other medical procedures |
| 03/14/2002 | WO2001070734A3 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 03/14/2002 | DE10023486C1 Ortho substituierte Anthranilsäureamide und deren Verwendung als Arzneimittel Ortho-substituted anthranilic acid amides and their use as medicaments |
| 03/14/2002 | CA2422204A1 Human antibodies against pseudomonas aeruginosa lps derived from transgenic mice |
| 03/13/2002 | EP1185271A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185247A1 Anti-inflammatory bioactive glass particulates |
| 03/13/2002 | EP0874634B1 Control of healing process |
| 03/07/2002 | WO2002017878A1 Lung surfactant compositions with dynamic swelling behaviour |
| 03/07/2002 | WO2001068033A3 Il-8 receptor antagonists |
| 03/07/2002 | DE10041423A1 Biphenylderivate Biphenyl |
| 03/07/2002 | CA2419606A1 Lung surfactant compositions with dynamic swelling behaviour |
| 03/06/2002 | EP1183233A2 Bradykinin receptor antagonists |
| 03/06/2002 | CN1339068A Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 03/06/2002 | CN1338943A Use of VEGF-C or VEGF-D gene or protein to prevent resitenosis |